Clinical Trials Browser

Interventional × nilotinib × Head & Neck × Clear all

NCT01871311 2019-02-08

A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors

Phase 1 Terminated

GastrointestinalHead & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Colorectal Neoplasms